Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Lee Jia |
| Publication date | June 27, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |